Biotech by today's price change
How far the share price has moved since the previous close.
Repligen leads the 24 biotech ranked by today's price change, at +6.76%, ahead of Scholar Rock Holding (+5.92%) and Twist Bioscience (+5.62%). Figures as of 18 Nov 2026, 15:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Repligen+6.76%
- Median
- +1.14%
- Combined market value
- NOK 8.23T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Today ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | RepligenRGEN · Health Care | +6.76% | NOK 107.3B | NOK 1,678.23 | 6.76% up | 5% up | ||
| 2 | Scholar Rock HoldingSRRK · Health Care | +5.92% | NOK 56.5B | NOK 462.81 | 5.92% up | 14% up | ||
| 3 | Twist BioscienceTWST · Health Care | +5.62% | NOK 78.2B | NOK 1,146.51 | 5.62% up | 340% up | ||
| 4 | CRISPR TherapeuticsCRSP · Health Care | +4.91% | NOK 39.6B | NOK 408.24 | 4.91% up | 21% down | ||
| 5 | ImmunityBioIBRX · Health Care | +4.39% | NOK 67.4B | NOK 63.34 | 4.39% up | 193% up | ||
| 6 | Krystal BiotechKRYS · Health Care | +3.53% | NOK 88.8B | NOK 2,995.72 | 3.53% up | 46% up | ||
| 7 | Kodiak SciencesKOD · Health Care | +2.27% | NOK 62.7B | NOK 959.54 | 2.27% up | 396% up | ||
| 8 | Adaptive BiotechnologiesADPT · Health Care | +1.90% | NOK 45.5B | NOK 281.37 | 1.90% up | 88% up | ||
| 9 | Kymera TherapeuticsKYMR · Health Care | +1.75% | NOK 102.3B | NOK 1,198.41 | 1.75% up | 87% up | ||
| 10 | argenxARGX · Health Care | +1.64% | NOK 587B | NOK 9,334.04 | 1.64% up | 4% up | ||
| 11 | ImmunovantIMVT · Health Care | +1.60% | NOK 67.7B | NOK 327.02 | 1.60% up | 43% up | ||
| 12 | Halozyme TherapeuticsHALO · Health Care | +1.25% | NOK 107.4B | NOK 941.81 | 1.25% up | 37% up | ||
| 13 | ExelixisEXEL · Health Care | +1.04% | NOK 163.7B | NOK 670.81 | 1.04% up | 63% up | ||
| 14 | ModernaMRNA · Health Care | +0.37% | NOK 814B | NOK 2,011.80 | 0.37% up | 755% up | ||
| 15 | Bio-TechneTECH · Health Care | +0.14% | NOK 110.7B | NOK 704.93 | 0.14% up | 26% up | ||
| 16 | BioNTechBNTX · Health Care | +0.13% | NOK 204.2B | NOK 823.56 | 0.13% up | 16% down | ||
| 17 | BiogenBIIB · Health Care | +0.08% | NOK 359.6B | NOK 2,432.78 | 0.08% up | 49% up | ||
| 18 | QiagenQGEN · Health Care | -0.09% | NOK 99.5B | NOK 481.76 | 0.09% down | 12% up | ||
| 19 | VaxcytePCVX · Health Care | -0.17% | NOK 91B | NOK 574.76 | 0.17% down | 22% up | ||
| 20 | Gilead SciencesGILD · Health Care | -0.28% | NOK 2.04T | NOK 1,645.67 | 0.28% down | 33% up | ||
| 21 | Revolution MedicinesRVMD · Health Care | -0.40% | NOK 339.7B | NOK 1,570.55 | 0.40% down | 131% up | ||
| 22 | Neurocrine BiosciencesNBIX · Health Care | -1.15% | NOK 160.9B | NOK 1,589.65 | 1.15% down | 20% up | ||
| 23 | AmgenAMGN · Health Care | -1.19% | NOK 2.37T | NOK 4,385.60 | 1.19% down | 34% up | ||
| 24 | CG OncologyCGON · Health Care | -1.89% | NOK 67B | NOK 750.63 | 1.89% down | 85% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6924 NOK).
Questions and answers
Which biotech rank first by today's price change?
Repligen (+6.76%), Scholar Rock Holding (+5.92%) and Twist Bioscience (+5.62%) are the top three of the 24 biotech ranked by today's price change as of 18 Nov 2026, 15:06 UTC.
How many biotech are in this ranking?
24 are ranked by today's price change.
What are these biotech worth together?
The 24 biotech ranked by today's price change have a combined market value of NOK 8.23T as of 18 Nov 2026, 15:06 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Biotech by today's price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.